Estradiol Patch Dosage Guide for Menopause: 0.014–0.1 mg/Day Explained

This estradiol patch dosage guide covers the seven strengths used in the United States, from 0.014 to 0.1 mg/day. The number printed on your patch is a daily delivery rate— how much estrogen passes through your skin in 24 hours — not the total amount of drug inside. Starting strengths and change schedules differ by product and by the reason you’re being treated.

By The HRT Index Editorial Team. Educational research based on current FDA product labeling and authoritative medical sources. Not medical advice, and not reviewed by a clinician.

Last verified: June 2026. Last updated: June 24, 2026.

You picked up your prescription, read the box, and there it was — a tiny number like 0.05 mg/day. And the first thought most women have is the same one: is that a lot, or barely anything?

Here’s the honest bottom line: there’s no single “correct” estradiol patch dose. The usual approach in the product labels is to begin at a lower strength and adjust based on how you respond. The right strength depends on your symptoms, your treatment goal, and your health history — not on where the number lands on a chart. And if you have a uterus, an estrogen patch isn’t the whole picture; you’ll also need a progestogen to protect your uterine lining (more on that below).

One important exception:there’s a 0.014 mg/day patch (Menostar) that’s approved only to help prevent bone loss — not to treat hot flashes.

Here’s what those numbers mean at a glance:

mcg = micrograms. 1 mg = 1,000 mcg, so 0.05 mg and 50 mcg are the exact same amount — your label just uses one or the other.

What we checked for this guide

We didn’t paraphrase other blogs. We read the source labels. Specifically, we confirmed:

• The available strengths and change schedules from current U.S. product labels (FDA / DailyMed).
• The label-stated starting doses, which differ by product and by the reason you’re being treated.
• Which products contain estrogen alone versus estrogen plus a progestin.
• How much total estradiol is built into selected patches.
• The FDA’s 2026 labeling changes, and which product categories were updated first.

What does an estradiol patch dose like “0.05 mg/day” actually mean?

The number on your patch is a daily delivery rate— how much estradiol passes through your skin in 24 hours — not the total amount of drug inside the patch. Two different patches can both say “0.05 mg/day” yet hold very different total amounts of estradiol, because they’re different sizes and worn for different lengths of time. More total estradiol in a patch does not mean a stronger daily dose.

We pulled the exact total-content numbers straight from the FDA labels of two patches that are still sold today — both at the same0.05 mg/day delivery rate:

Source: Climara and Vivelle-Dot FDA prescribing information (see Sources). The discontinued Alora patch held 1.5 mg at 0.05 mg/day.

Climara holds nearly five timesthe total estradiol of Vivelle-Dot — yet both deliver the same 0.05 mg per day. The bigger total reflects how long the patch is worn, not a stronger dose. Don’t compare patches by size or total contents. Confirm the exact product, the mg/day rate, the schedule, and the application instructions with your pharmacist.

What the number on your patch does not tell you

• Whether that dose is right for you.
• Whether the patch is once-weekly or twice-weekly (the schedule matters as much as the number).
• Whether it contains estrogen alone or also a progestin.
• Whether you also need separate progesterone (you might — see below).
• Whether lingering symptoms mean you need more estrogen, or something else entirely.

What estradiol patch strengths are available in the United States?

Across current U.S. estradiol patch labels, seven daily delivery rates appear: 0.014, 0.025, 0.0375, 0.05, 0.06, 0.075, and 0.1 mg/day. No single product carries all of them, the schedule (once- vs twice-weekly) varies, and one product (Menostar, 0.014 mg/day) is for bone protection only. The practical answer is always your exact product, its strengths, and its schedule.

Patches fall into two groups by how often you change them.

Twice-weekly estradiol patches (changed every 3–4 days)

Once-weekly estradiol patches (changed every 7 days)

Source: FDA / DailyMed prescribing information for each product (see Sources).

A quick reminder about “matching” strengths

A generic patch that lists the same mg/day rate as a brand isn’t automatically the official substitute with the same instructions and application sites. If your pharmacy swaps you to a different product, confirm the exact name, strength, schedule, and how to use it — and ask whether it’s an approved substitution.

Why Menostar isn’t a hot-flash patch

Menostar delivers just 0.014 mg/day, once a week, and its FDA approval is specifically for helping prevent bone loss after menopause — not for treating vasomotor symptoms (the medical term for hot flashes and night sweats). If your main problem is hot flashes and someone mentions Menostar, that’s worth a direct question about whether it fits your goal.

What are the label-stated starting doses for menopause symptoms?

There is no single starting dose shared by every estradiol patch. Once-weekly Climara starts at 0.025 mg/day in its label. Several twice-weekly patches (Vivelle-Dot, Minivelle, and generic estradiol patches) start at 0.0375 mg/day for hot flashes. Starting doses for bone-loss prevention are often lower. The “right” start depends on the product and the reason you’re being treated.

Source: FDA prescribing information for each product (see Sources). The discontinued Alora label started at 0.05 mg/day for hot flashes — included for reference only.

“Starting dose” is label language, not an instruction for you. Your clinician may choose a different product or strength based on your goal, your symptoms, your history, and how you respond. A lower starting dose isn’t a “weak” dose or a sign your treatment is half-hearted.

When estrogen is prescribed only to prevent osteoporosis, current labels tell clinicians to consider non-estrogen medications first, and to weigh estrogen for women at meaningful risk of bone loss.

What changed with the FDA in late 2025 and early 2026

• November 2025: the FDA requestedclass-wide labeling changes — removing boxed-warning language about cardiovascular disease, breast cancer, and probable dementia, and removing the “lowest effective dose for the shortest time” line.
• February 12, 2026: the FDA approved the first six updated labels. None of them were estradiol patches. (More on what this means for your patch below.)

The practical takeaway: the old “shortest time possible” framing is being walked back, but the core idea hasn’t changed — your dose should still be individualized and reviewed over time, not set once and forgotten.

Is 0.025, 0.05, or 0.1 mg a low or high estradiol patch dose?

Words like “low,” “standard,” and “high” are used inconsistently across the internet. Among current estradiol-only patches, 0.1 mg/day is the highest single-patch strength for most products — but that doesn’t make it a personal maximum, and it doesn’t mean 0.025 mg/day is “not enough.” Whether a dose is right is about your symptoms and safety, not where the number sits on a chart.

Here’s honest context for the three numbers people ask about most:

• 0.025 mg/day is a real, FDA-approved strength and a labeled starting dose for several uses. It is not a verdict that your treatment is too cautious.
• 0.05 mg/dayis a common strength. It sits in the middle of the range on most products. It is not a universal “normal.”
• 0.1 mg/day is the highest single-patch strength for most estradiol-only products. Reaching it should be a clinical decision — never a cue to add a second patch or change your patch early on your own.

The questions women actually ask

• Why did I get a 0.025 patch — is that even doing anything?
• I’m honestly nervous to go up from 0.025 to 0.0375.
• My hot flashes got better but didn’t stop. Is my dose too low?
• The pharmacy gave me a different brand. Did my treatment just change?
• My patch keeps lifting at the edges before change day.

If you recognize yourself here — good. It means you’re asking the right things. The rest of this guide addresses each one directly. And for the placement and sticking questions, see our complete guide to applying an estradiol patch.

What’s the difference between once-weekly and twice-weekly estradiol patches?

Once-weekly and twice-weekly patches are designed to be changed on different schedules, even when they deliver the same daily amount of estradiol. Follow the schedule for the exact product you were given. The schedule isn’t a dose difference — it’s a wear-time difference.

• Once weekly (change every 7 days): Climara, Menostar. (Climara Pro, a combination patch, is also once weekly.)
• Twice weekly (change every 3–4 days): Vivelle-Dot, Minivelle, and generic estradiol patches like Dotti and Lyllana. (CombiPatch is also twice weekly.)

Neither schedule is “stronger.” Some women prefer changing a patch once a week; others find a smaller twice-weekly patch sticks better or irritates their skin less. It’s a fit-and-lifestyle choice, made with your prescriber. For the full how-to on application and scheduling, see our step-by-step estradiol patch application guide.

Where should I apply an estradiol patch?

Most labels agree on the core rules — clean, dry, lotion-free skin on the lower belly or upper buttock, never on the breasts, pressed firmly and rotated to a new spot each time. But the exact approved sites can differ a little by product, so use the spot named in the instructions for your specific patch.

Rules nearly every label shares:

• Put it on clean, dry, lotion-free skin.
• Never apply it to your breasts, and avoid your waistline where tight clothing can rub it off.
• Press firmly for about 10 seconds, especially around the edges.
• Rotate sites. Don’t put a new patch on the exact same spot within a week.
• Don’t apply over cuts, rashes, or irritated skin.

For the full brand-by-brand placement chart and shower rules, see our complete estradiol patch application guide.

Do I need progesterone if I have a uterus?

This isn’t decided by your patch strength, and the exact regimen depends on your history. But the need for a protection plan is real, and any unexpected bleeding should be reported to your clinician promptly.

Two ways the progestogen can be delivered

• A separate prescription — a progesterone or progestin pill or other form, prescribed alongside your estradiol patch.
• A combination patch that already contains both hormones (see the next section).

Questions to ask your clinician

• “Do I have a uterus or any remaining uterine lining that needs protection?”
• “What’s my progesterone plan — and is it daily or only part of the month?”
• “What kind of bleeding should I expect, and what should I report?”
• “Does my current patch contain estrogen only, or is it a combination?”

For a deeper walk-through, see our full guide: Do you need progesterone if you have a uterus?

Are estradiol-only and combination HRT patches the same?

No. Estradiol-only patches contain just estrogen. Combination patches — Climara Pro and CombiPatch — also contain a progestin, which changes what they treat, who they’re for, and how they’re counseled. We list them separately so no one mistakes the estrogen number for the patch’s full hormone content.

Source: Climara Pro and CombiPatch FDA / DailyMed prescribing information (see Sources).

How can I tell whether my estradiol patch dose needs a clinical review?

Lingering symptoms, new side effects, a patch that won’t stay on, an unclear schedule, or a pharmacy brand swap can all be good reasons to ask for a review — but none of them proves your dose should go up or down. Write down what’s happening and ask your prescriber to look at your goal, your usage, your risks, and your options together.

Reasons it’s reasonable to check in:

• Your symptoms are still disrupting your life.
• Your symptoms got better, then came back.
• New side effects showed up after you started or changed your patch.
• The patch keeps lifting or falling off.
• You’re not sure when you’re supposed to change it.
• You started a new medicine or have a new health condition.
• No one ever explained the progesterone piece and you have a uterus.
• Your pharmacy switched you to a different manufacturer or product.

Write this down before your appointment

A two-minute log makes your visit far more useful. You can also use our free 7-day HRT response log to track exactly what to bring. Here’s the quick version:

Is there an estradiol patch shortage in 2026, and what should I do?

Yes — supply has been tight. The American Society of Health-System Pharmacists (ASHP) reports manufacturer- and strength-specific constraints, not a clean “every patch is gone” shortage. Some products and strengths have been on backorder while others stayed available, and it varies by pharmacy and region. The safest move is not to ration or cut your patches, but to ask your pharmacist and prescriber to confirm your exact product or a suitable alternative.

• Throughout 2025 and into 2026, demand for menopause hormone therapy rose sharply, and several estradiol patch products and strengths landed on backorder or limited supply. ASHP has tracked the affected products in its drug-shortage bulletin.
• This was notformally listed as a shortage on the FDA’s own drug-shortage database as of early 2026, even though many women reported calling multiple pharmacies. Availability genuinely varies by region and day.
• The discontinued Alorapatch is a separate matter — it’s gone for good, not “in shortage.”

What to do if your strength is hard to find:

• Don’t ration, stretch, or cut your patches to make them last.
• Ask your pharmacist whether a different brand or a generic at your strength is in stock, and whether your prescriber will allow substitution.
• Ask your prescriber about other forms of the same hormone — an estradiol gel or spray is also transdermal and is often a close stand-in for a patch, while oral tablets are another option. Any switch should be guided by your clinician.

Supply status reflects the ASHP drug-shortage bulletin, last updated April 22, 2026; this page checked June 2026. Status changes often — confirm current availability with your pharmacy.

What if my patch falls off, I miss a change, or I want to cut it?

Check your specific product’s instructions, because the right answer depends on the patch and how long it was off. As a general rule: if a patch falls off, reapply it or put a fresh one on a different spot and keep your original schedule— don’t double up to “catch up.” And don’t cut a patch on your own to lower your dose; ask for a lower marketed strength instead.

If your patch falls off or lifts

If a patch comes loose, press it back down; if it won’t re-stick, apply a new patch to a different area and stay on your original change schedule. Don’t restart the clock, and don’t add an extra patch.

If you miss a change day

Change it as soon as you remember and get back on your normal schedule — and don’t apply two patches to make up for lost time unless you’re specifically told to.

If you’re tempted to cut a patch

None of the U.S. patient instructions tells you to cut an estradiol patch. Whether cutting is even possible depends on the patch — so don’t do it unless your prescriber and pharmacist have confirmed it’s OK for your exact product. When you need a lower amount, the safer route is asking for a lower marketed strength.

If you’re thinking about wearing two patches

Clinicians do sometimes deliberately prescribe more than one system for a specific reason — but that’s a decision they make and monitor, not something to try on your own.

If the patch won’t stay on no matter what

Repeated falling-off may interrupt how much you’re absorbing, and it’s worth raising with your pharmacist or prescriber. A different patch, a different application site, or a different delivery method (like a gel) might work far better for your skin and routine. See our estradiol patch application guide for sticking tips.

Who should not use a systemic estradiol patch?

Systemic estrogen patches have firm “don’t use this” situations that you can’t judge from the patch strength. Current labels list contraindications including unexplained vaginal bleeding; known, suspected, or past breast cancer; other estrogen-sensitive cancers; active or past blood clots; active or recent stroke or heart attack; liver problems; known blood-clotting disorders; a serious allergy to the product; and pregnancy.

• Vaginal bleeding that hasn’t been explained by a clinician yet.
• Breast cancer — known, suspected, or in your past.
• Other cancers that feed on estrogen.
• Blood clots in the legs (DVT) or lungs (PE) — now or in the past.
• Stroke or heart attack — recent or past.
• Liver disease or impaired liver function.
• Known clotting disorders that raise clot risk.
• A serious allergic reaction to the patch or its ingredients.
• Pregnancy.

This isn’t the full label, and some items have nuance a clinician will weigh for you. The point is simple: the right patch dose only matters after you and your clinician confirm a patch is safe for you in the first place.

What are the main risks, and when should I contact a clinician?

Even when an estrogen patch is appropriate, it carries real risks. Review your product label and your personal history with a clinician, report unexpected vaginal bleeding promptly, and get urgent help for anything that could signal a blood clot or stroke.

Call your clinician soon if you notice

• New or unexplained vaginal bleeding.
• New breast lumps or changes.
• Side effects that are significant or won’t settle.
• A new or worsening migraine pattern.
• An upcoming surgery or a long stretch of being immobile (this can change clot risk).
• A new diagnosis that might affect hormone therapy.

About the “patches are safer than pills” idea

Because a patch sends estradiol through your skin instead of through your digestive system and liver, the route is different from a tablet. ACOG notes that oral estrogen can have a clot-promoting effect, while transdermal estrogen appears to have little or no effect on those clotting markers. The Menopause Society notes that transdermal routes may carry a lower risk of blood clots and stroke than oral estrogen.

But “lower risk than pills” is not “no risk.” The route doesn’t erase the need to weigh your own history — clots, heart or stroke history, certain cancers, liver disease, migraines, and how long it’s been since menopause all factor in.

Did the FDA remove the boxed warning from estradiol patches in 2026?

Not yet for patches, as of this page’s verification date. The FDA requested class-wide warning changes in November 2025 and approved the first six updated product labels on February 12, 2026 — and none of those six were estradiol patches. So your patch’s printed warning may still show the older language. The endometrial-cancer boxed warning for estrogen-alone products is staying.

What’s true: in November 2025, after a full scientific review, the FDA requested removal of its most prominent warnings — about cardiovascular disease, breast cancer, and probable dementia — from menopause hormone therapy labels. The agency also pointed to evidence that, for many women, the benefits can be greatest when therapy starts before age 60 or within about 10 years of menopause.

What’s also true, and easy to miss: this is a rollout, not a switch. The first batch of six approved labels (February 12, 2026) was Bijuva, Divigel, Cenestin, Enjuvia, Prometrium, and Estring — a combination capsule, a gel, two oral estrogens, an oral progesterone, and a vaginal ring. No patches.

So if you read your estradiol patch leaflet today and it still carries a strong boxed warning, that doesn’t mean the news was fake — it means your patch’s label simply hasn’t been updated yet.

What did not change:

• You still need an individual benefit-and-risk conversation.
• The “don’t use if…” situations and real risks still exist.
• Your product’s specific instructions still apply.
• Endometrial protection is still essential for estrogen-alone use with a uterus — the FDA kept that warning on purpose.
• A label update never sets your personal dose.

How long should I stay on one estradiol patch strength before a dose review?

There’s no universal internet timetable that fits every woman or every product. Current labels direct clinicians to reevaluate treatment periodically — some say to attempt tapering or stopping at three- to six-month intervals — while new bleeding, serious symptoms, or significant side effects should be reported sooner.

Three different questions hide inside “how long?”:

1. When will symptoms start to change? That varies, and it’s a good thing to ask when you’re prescribed.
2. When did your clinician plan to reassess? Many will pick a follow-up point with you.
3. Is something happening that means you should call sooner? New bleeding or a worrying symptom always beats waiting.

A simple thing to ask at the start: “When should we review this, what are we hoping to see, and what should make me call you before then?”

Is a systemic patch the right choice for vaginal symptoms alone?

An estradiol patch sends estrogen through your whole body — the right tool for body-wide symptoms like hot flashes. If your only symptoms are vaginal or urinary — dryness, irritation, painful sex — a low-dose local vaginal product may be the more targeted option to discuss.

• A systemic patch is designed to raise estrogen throughout your body.
• Low-dose local vaginal products(certain creams, tablets or inserts, and the Estring ring) work mainly where they’re placed, using very small amounts.
• Femring looks like a vaginal ring but is systemic— it’s labeled for hot flashes and delivers 0.05 or 0.1 mg/day. Don’t lump it in with local-only products.

If it’s purely vaginal symptoms, a local product might be a better fit. To compare those options, see our guides on vaginal estrogen and vaginal estrogen vs systemic estrogen.

What should I ask before starting or changing an estradiol patch?

The most useful pre-visit questions nail down your exact product, your treatment goal, your schedule, your progesterone plan, when you’ll review the dose, and what to do if a patch falls off. Walking in with a written list means you leave with a real plan — not just a number on a slip.

Copy or print this checklist and bring it:

1. What’s the exact product name you’re prescribing?
2. Is it estrogen only, or a combination patch?
3. What does the printed rate (like 0.05 mg/day) mean for me?
4. Is it once weekly or twice weekly?
5. Which symptom or goal are we treating?
6. What improvement should we be watching for?
7. When should we review the dose and whether I still need it?
8. What side effects or bleeding should make me call you?
9. What’s my progesterone or uterine-protection plan?
10. What should I do if the patch falls off?
11. What happens if the pharmacy swaps my brand?
12. Are there reasons in my history that make a different route (gel or pill) better?
13. When would seeing someone in person be the smarter starting point?

How did The HRT Index verify this estradiol patch dosage guide?

For this medication-label guide, we used the source-verification steps of The HRT Index Verification Standard: we read the current FDA / DailyMed label for each product, recorded the date we checked, kept FDA-approved and compounded options strictly separate, and flagged anything we couldn’t confirm instead of guessing.

• Every strength, schedule, and starting dose was transcribed directly from a current FDA / DailyMed product label.
• Total patch contents are listed only where the label states them clearly.
• FDA-approved products and compounded products are kept separate and never presented as equivalent.
• Time-sensitive facts — supply status and the 2026 FDA labeling changes — are dated.

We re-check the labels and FDA status on this page periodically; it was last verified in June 2026. Found an error or a changed label? Tell us the product name and the source, and we’ll correct it and date the update.

Frequently asked questions about estradiol patch dosage

The most common follow-ups are about whether a strength is “low,” how the schedules differ, what to do after a missed change, whether you need progesterone, and whether a patch can be cut. The answer almost always depends on your exact product and situation — and dose questions belong with your prescriber.

The bottom line

Your estradiol patch number is a daily delivery rate, not the total drug inside — and the appropriate strength is the one chosen to meet your treatment goal safely, with a clinician, not the one that looks biggest on a chart. Follow your prescribed starting strength and review it based on how you respond, clarify the progestogen and endometrial-protection plan if you have a uterus, follow your exact product’s schedule, and don’t cut or stack patches on your own. In 2026, also know that supply has been tight and the FDA’s warning changes are rolling out product by product.

Get those few things right and you walk into your appointment more prepared than most — which is the entire point of this page.